Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 3, 2025 • 1:41 PM ET

Date/Time Source News Release
05/15/2025 04:05 PM EDT Business Wire RenovoRx Reports First Quarter 2025 Financial Results and Business Highlights
05/14/2025 08:30 AM EDT Business Wire RenovoRx to Participate in Fireside Chat at A.G.P. Virtual Healthcare Company Showcase on May 21st
05/06/2025 08:30 AM EDT Business Wire U.S. Patent Office Issues New Patent to RenovoRx for Novel Trans-Arterial Micro-Profusion (TAMP(TM)) Therapy Platform
05/01/2025 08:30 AM EDT Business Wire RenovoRx to Host First Quarter 2025 Financial Results Conference Call on May 15th at 4:30 p.m. ET
04/29/2025 08:30 AM EDT Business Wire Johns Hopkins Medicine Initiates Patient Enrollment for RenovoRx's Ongoing Phase III TIGeR-PaC Clinical Trial
04/16/2025 08:30 AM EDT Business Wire RenovoRx Increases U.S. Production of RenovoCath® Devices to Meet Growing Demand from Oncology Community
04/04/2025 08:30 AM EDT Business Wire RenovoRx to Present at LD Micro Invitational XV Conference in New York on April 10th
04/01/2025 08:30 AM EDT Business Wire RenovoRx Reports Initial Revenues from RenovoCath® Commercialization, and Provides Update on Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial
03/28/2025 08:00 AM EDT Business Wire RenovoRx Highlights New Human Pharmacokinetic Data Abstract at SSO 2025 Annual Meeting
03/26/2025 08:00 AM EDT Business Wire RenovoRx Pre-Clinical Results Supporting TAMP(TM) as a Targeted Locoregional Drug Delivery Platform to Receive Award at SIR 2025 Annual Scientific Meeting
Page

Additional News

As of June 3, 2025 • 1:41 PM ET

Date/Time Source News Release
05/15/2025 09:07 PM EDT SeekingAlpha RenovoRx, Inc. (RNXT) Q1 2025 Earnings Conference Call Transcript
05/15/2025 07:30 PM EDT Zacks RenovoRx, Inc. (RNXT) Reports Q1 Loss, Lags Revenue Estimates
05/15/2025 04:12 PM EDT SeekingAlpha RenovoRx GAAP EPS of -$0.08 in-line, revenue of $0.20M beats by $0.02M
05/15/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, May 15th, 2025
05/15/2025 05:31 AM EDT US Earnings Reports Expected earnings - RenovoRx Inc.
05/14/2025 06:48 PM EDT KlickAnalytics RNXT - Historical Price Movements Surrounding Earnings
05/14/2025 06:43 PM EDT KlickAnalytics RNXT - Historical Earnings Price Analysis
04/16/2025 11:10 AM EDT Baystreet Renovo Gains on Bringing Forward RenovoCath
04/02/2025 05:30 AM EDT US Earnings Reports Expected earnings - RenovoRx Inc.
02/12/2025 02:15 PM EST InvestorBrandNetwork InvestorNewsBreaks - RenovoRx Inc. (NASDAQ: RNXT) Announces $12.1M Underwritten Public Offering
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.